Screening adolescents and young women.

Lori A Boardman, Katina Robison
Author Information
  1. Lori A Boardman: Department of Clinical Sciences, University of Central Florida College of Medicine, Orlando, FL 32827, USA. Lori.Boardman@ucf.edu

Abstract

Recent guidelines from multiple organizations stress screening initiation no earlier than the age of 21 years and increased screening intervals for women aged 21 to 29 years. Primary prevention with human papillomavirus vaccination has the potential to significantly affect the development of high-grade cervical lesions, including cancer, and will likely affect screening guidelines in the future.

References

  1. J Natl Cancer Inst. 2010 Mar 3;102(5):325-39 [PMID: 20139221]
  2. PLoS One. 2012;7(11):e49751 [PMID: 23185426]
  3. Am J Obstet Gynecol. 2011 Feb;204(2):128.e1-7 [PMID: 21145032]
  4. Int J Cancer. 2013 Jan 1;132(1):198-207 [PMID: 22532127]
  5. Am J Obstet Gynecol. 2007 Oct;197(4):346-55 [PMID: 17904957]
  6. Ann Intern Med. 2009 Nov 3;151(9):602-11 [PMID: 19884621]
  7. Obstet Gynecol. 2009 Jun;113(6):1422-1425 [PMID: 19461460]
  8. Cancer Causes Control. 2012 Feb;23(2):281-8 [PMID: 22108842]
  9. J Pediatr. 1998 Feb;132(2):277-84 [PMID: 9506641]
  10. J Public Health (Oxf). 2012 Dec;34(4):539-47 [PMID: 22707556]
  11. MMWR Morb Mortal Wkly Rep. 2013 Jan 4;61(51-52):1038-42 [PMID: 23282861]
  12. Infect Agent Cancer. 2012 Dec 29;7(1):38 [PMID: 23273245]
  13. Can Fam Physician. 2009 Apr;55(4):376-7 [PMID: 19366945]
  14. Obstet Gynecol. 2009 Dec;114(6):1232-1238 [PMID: 19935024]
  15. Arch Intern Med. 2010 Jun 14;170(11):977-85 [PMID: 20548011]
  16. JAMA. 2007 Feb 28;297(8):813-9 [PMID: 17327523]
  17. CA Cancer J Clin. 2012 May-Jun;62(3):147-72 [PMID: 22422631]
  18. J Low Genit Tract Dis. 2008 Apr;12(2):71-81 [PMID: 18369299]
  19. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):650-7 [PMID: 16150255]
  20. Arch Intern Med. 2008 Sep 22;168(17):1881-9 [PMID: 18809815]
  21. Lancet. 2001 Jun 9;357(9271):1831-6 [PMID: 11410191]
  22. JAMA. 2001 Jun 20;285(23):2995-3002 [PMID: 11410098]
  23. Vaccine. 2006 Aug 31;24 Suppl 3:S3/171-7 [PMID: 16844268]
  24. Obstet Gynecol. 2005 Feb;105(2):325-32 [PMID: 15684160]
  25. BJOG. 2012 Jan;119(2):236-44 [PMID: 21790951]
  26. J Infect Dis. 2005 Mar 1;191(5):731-8 [PMID: 15688287]
  27. N Engl J Med. 1998 Feb 12;338(7):423-8 [PMID: 9459645]
  28. CA Cancer J Clin. 2002 Nov-Dec;52(6):342-62 [PMID: 12469763]
  29. Pediatrics. 2011 Nov;128(5):830-9 [PMID: 22007006]
  30. Lancet. 2004 Nov 6-12;364(9446):1678-83 [PMID: 15530628]
  31. Am J Obstet Gynecol. 2007 Aug;197(2):141.e1-6 [PMID: 17689626]
  32. MMWR Morb Mortal Wkly Rep. 2012 Aug 31;61(34):671-7 [PMID: 22932301]
  33. BMC Infect Dis. 2011 Jan 12;11:13 [PMID: 21226933]
  34. J Gynecol Oncol. 2012 Oct;23(4):282-7 [PMID: 23094132]
  35. BMJ. 2009 Jul 28;339:b2968 [PMID: 19638651]
  36. Diagn Cytopathol. 2013 Jul;41(7):588-94 [PMID: 22833404]
  37. Obstet Gynecol. 2012 Nov;120(5):1117-23 [PMID: 23090530]
  38. Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):699-707 [PMID: 21173170]
  39. J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27 [PMID: 23519301]
  40. Ann Intern Med. 2000 May 16;132(10):810-9 [PMID: 10819705]
  41. J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23 [PMID: 23104323]
  42. Health Rep. 2010 Jun;21(2):37-42 [PMID: 20632523]
  43. BJOG. 2011 Aug;118(9):1031-41 [PMID: 21449928]
  44. Obstet Gynecol. 2009 Sep;114(3):504-510 [PMID: 19701027]
  45. Obstet Gynecol. 2005 Apr;105(4):741-6 [PMID: 15802399]
  46. Arch Pediatr Adolesc Med. 1999 Oct;153(10):1046-54 [PMID: 10520612]
  47. Obstet Gynecol. 2012 Nov;120(5):1222-38 [PMID: 23090560]
  48. Obstet Gynecol. 2010 Jul;116(1):76-84 [PMID: 20567171]
  49. Ann Intern Med. 2012 Jun 19;156(12):880-91, W312 [PMID: 22711081]
  50. Int J Cancer. 2013 Jun 15;132(12):2833-8 [PMID: 23180157]
  51. Obstet Gynecol. 2012 Feb;119(2 Pt 1):227-31 [PMID: 22270273]
  52. J Infect Dis. 2010 Dec 15;202(12):1789-99 [PMID: 21067372]
  53. Am J Epidemiol. 2003 Feb 1;157(3):218-26 [PMID: 12543621]
  54. Obstet Gynecol. 2010 Dec;116(6):1373-1380 [PMID: 21099605]
  55. J Infect Dis. 1995 Apr;171(4):1026-30 [PMID: 7706782]
  56. J Infect Dis. 2011 Aug 15;204(4):562-5 [PMID: 21791658]
  57. J Low Genit Tract Dis. 2010 Apr;14(2):97-102 [PMID: 20354416]
  58. Lancet. 2006 Feb 11;367(9509):489-98 [PMID: 16473126]
  59. J Infect Dis. 2012 Aug 15;206(4):504-11 [PMID: 22696500]
  60. Am J Obstet Gynecol. 1999 Mar;180(3 Pt 1):571-7 [PMID: 10076130]
  61. CMAJ. 2011 Mar 22;183(5):563-8 [PMID: 21398237]
  62. JAMA. 2004 May 5;291(17):2100-6 [PMID: 15126438]
  63. Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9 [PMID: 22862799]
  64. J Low Genit Tract Dis. 2010 Jan;14(1):73-80 [PMID: 20043357]
  65. Sex Transm Infect. 2011 Dec;87(7):544-7 [PMID: 21970896]
  66. J Pediatr Adolesc Gynecol. 2007 Oct;20(5):269-74 [PMID: 17868892]

Grants

  1. L30 HD070361/NICHD NIH HHS

MeSH Term

Adolescent
Adult
Child
Colposcopy
Consensus
Developing Countries
Female
Humans
Mass Screening
Papanicolaou Test
Papillomavirus Infections
Papillomavirus Vaccines
Practice Guidelines as Topic
Sexually Transmitted Diseases
Uterine Cervical Neoplasms
Vaginal Smears
Young Adult
Uterine Cervical Dysplasia

Chemicals

Papillomavirus Vaccines

Word Cloud

Created with Highcharts 10.0.0screeningguidelines21yearswomenaffectRecentmultipleorganizationsstressinitiationearlierageincreasedintervalsaged29Primarypreventionhumanpapillomavirusvaccinationpotentialsignificantlydevelopmenthigh-gradecervicallesionsincludingcancerwilllikelyfutureScreeningadolescentsyoung

Similar Articles

Cited By (3)